Analysis of the outcomes of myocardial infarction against the background of chronic obstructive pulmonary disease among residents of the Astrakhan region

   Objective. To analyse the course of coronary heart disease within a year after the development of myocardial infarction in residents of Astrakhan region with chronic obstructive pulmonary disease.

   Materials and Methods. We examined 325 patients with myocardial infarction, residents of Astrakhan region. 195 patients had heart attacks against the background of COPD and 130 patients without COPD. During 12-month follow-up 30 people dropped out - 19 in the group of patients with myocardial infarction against COPD, 11 in the group of patients with myocardial infarction without COPD. Correspondingly, by the end of the observation period the number of patients under observation was: 176 - in the group of patients with myocardial infarction against COPD, and 119 - in the group of patients with myocardial infarction without COPD.

   Results. It was found that in patients with myocardial infarction against COPD the annual mortality from conditions associated with cardiovascular pathology was twice as frequent as in patients with MI without COPD. There was also a tendency to more frequent development of recurrent myocardial infarction. In the structure of mortality in patients with myocardial infarction against COPD and without COPD and there was a tendency to a more frequent occurrence of acute heart failure expressed stages (Killip III-IV) and decompensation of chronic heart failure as causes of mortality. The odds of developing a combined endpoint, including recurrent myocardial infarction, stroke and mortality from cardiac causes, among patients with myocardial infarction against COPD were 2.7 times higher compared to patients with myocardial infarction without COPD. The combined endpoint, which combines clinically significant events in patients with myocardial infarction, makes the existing differences in the outcomes of infarction in patients with and without COPD evident.

1. Glushchenko, V. A., Irklienko E. K. Cardiovascular morbidity is one of the most important problems of public health. Meditsina i organizatsiya zdravookhraneniya Medicine and organization of public health. 2019; 4 (1): 56–63. (In Russ.).

2. Bobrovskaya E. E., Burova N. N., Kon V. E. Predictors of complicated course and unfavorable prognosis of myocardial infarction. Arterial'naya gipertenziya = Arterial Hypertension. 2009; 15 (5): 539–542. (In Russ.).

3. Shishkina E. A., Khlynova O. V., Cheremnykh A. B. Prognozirovanie postgospital'noy letal'nosti u bol'nykh infarktom miokarda molodogo i srednego vozrasta. Doktor.Ru = Doktor.Ru. 2020; 19 (5): 24–29. (In Russ.). doi: 10.31550/1727-2378-2020-19-5-24-29.

4. Novikova R. A., Alekseychik S. E., Goncharik T. A., Alekseychik D. S., Sanvovich E. V. Recurrent myocardial infarction, causes of myocardial infarction, difficulties in diagnosis and prevention. Ekstrennaya meditsina = Emergency Medicine. 2017; 6 (2): 229–234. (In Russ.).

5. Oganov R. G., Denisov I. N., Simanenkov V. I., et al. Comorbid Pathology in Clinical Practice. Clinical guidelines. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular therapy and prevention. 2017; 16 (6): 5–56. (In Russ.). doi: 10.15829/1728-8800-2017-6-5-56

6. Drapkina O. M., Shutov A. M., Efremova E. V. Comorbidity, multimorbidity, dual diagnosis - synonyms or different concepts? Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2019; 18 (2): 65–69. (In Russ.). doi: 10.15829/1728-8800-2019-2-65-69.

7. Chaulin A. M., Duplyakov D. V. Comorbidity of chronic obstructive pulmonary disease and cardiovascular disease. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2021; 20 (3): 25–39. (In Russ.). doi: 10.15829/1728-8800-2021-2539.

8. Grigor'eva N. Yu., Mayorova M. V., Koroleva M. E., Samolyuk M. O. Peculiarities of formation and development of cardiovascular diseases in patients with chronic obstructive pulmonary disease. Terapevticheskiy arkhiv = Therapeutic Archives. 2019; 91 (1): 16-47. (In Russ.). doi: 10.26442/00403660.2019.01.000027.

9. Zafiraki V. K., Skaletskiy K. V., Namitokov A. M., Kosmacheva E. D., Shul'zhenko L. V., Omarov A. A., Ramazanov D. M. O. Chronic obstructive pulmonary disease as a factor of adverse cardiovascular prognosis after percutaneous coronary intervention for coronary heart disease. Kardiologiya = Cardiology. 2015; 55 (10): 41–45. (In Russ.).

10. Kuz'michev B. Yu., Voronina L. P., Tarasochkina D. S., Polunina O. S., Prokof'eva T. V., Lipnitskaya E. A., Polunina E. A. Hyperhomocysteinemia as a risk factor for complicated myocardial infarction against chronic obstructive pulmonary disease. Astrakhanskiy meditsinskiy zhurnal = Astrakhan Medical Journal. 2019; 14 (3): 79-87. (In Russ.). URL: https://www.astmedj.ru/jour/article/view/38/0.

11. Chichkova M. A., Zav'yalov B. G., Chichkov Yu. M., Kozlova O. S., Chichkov A. M., Kadiev G. M. Impact of Comorbid Pathology and Clinical Prognostic Factors on Outcomes of Myocardial Infarction in Elderly and Older Patients. Astrakhanskiy meditsinskiy zhurnal = Astrakhan Medical Journal. 2019; 14 (1): 101–107 (In Russ.).

12. The Fourth Universal Definition of Myocardial Infarction (2018). URL: https://russjcardiol.elpub.ru/jour/article/viewFile/3259/2531. (In Russ.).

13. Acute myocardial infarction with ST-segment elevation electrocardiogram. Clinical guidelines // Ministry of Health of the Russian Federation, Society of Emergency Cardiology Specialists. 2016. URL: http://wwwj3.ipksz.ru/images/Novosti2018/0811_2/ST.pdf. (In Russ.).

14. Diagnosis and treatment of patients with acute coronary syndrome without ST-segment elevation electrocardiogram. Clinical guidelines // Ministry of Health of the Russian Federation, Society of Emergency Cardiology Specialists. 2015. 95 p. URL: https://www.volgmed.ru/uploads/files/2018-10/90523-oks_bez_podema_st_na_ekg_2015_osnk.pdf. (In Russ.).

15. Global Initiative for Chronic Obstructive Lung Disease (2019) URL: https://goldcopd.org/pocketguidereferences/.